PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 19.11.2019 at 4:00 PM CET
Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (AU2012271625) Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection

Office : Australia
Application Number: 2012271625 Application Date: 14.06.2012
Publication Number: 2012271625 Publication Date: 30.01.2014
Publication Kind : B2
Prior PCT appl.: Application Number:US2012042426 ; Publication Number: Click to see the data
IPC:
C07K 14/02
A61K 36/06
A61K 39/29
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005
from viruses
01
DNA viruses
02
Hepadnaviridae, e.g. hepatitis B virus
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
06
Fungi, e.g. yeasts
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
12
Viral antigens
29
Hepatitis virus
CPC:
A61K 38/21
A61K 38/212
A61K 39/12
A61K 39/29
A61K 2039/523
C07K 14/005
C07K 2319/21
C07K 2319/35
C12N 15/81
C12N 2760/10122
C12N 2760/10134
C12N 2800/22
A61K 45/06
A61K 2039/645
C07K 2319/09
C07K 2319/40
Applicants: GlobeImmune, Inc.
Inventors:
Agents: FB Rice Pty Ltd
Priority Data: 61/497,039 14.06.2011 US
Title: (EN) Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection
Abstract: front page image
(EN) Disclosed are immunotherapeutic compositions and methods for preventing and/or treating hepatitis delta virus (HDV) infection, including yeast-based HDV immunotherapeutic compositions and methods of use of such compositions to prevent and/or treat HDV infection and symptoms and sequela thereof.
Also published as:
CA2838950EP2720716CN103732250US20140193362SG195383JP2014523878
EA201490015SG10201605265TNZ619761IN160/DELNP/2014ES2671381WO/2012/174220